ArticleTransfusion2026
Functional investigation of the RHD gene promoter: Molecular changes are rarely responsible for variant D phenotype in Thai donors.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundWhile modern technology is increasingly available to identify efficiently the molecular alterations responsible for variant phenotype, a subset of samples still escapes those analyses. In addition to the promoter region, two intronic regions containing GATA1 binding sites within the RHD gene locus were recently shown to modulate the transcriptional activity of the gene. We then thought to explore these regions in a subset of samples with unresolved genotypes. STUDY DESIGN AND
methodsThirty-three Thai donor samples (weak D, n = 10; D-negative, 23) were selected for molecular analysis by conventional Sanger sequencing. In parallel, a novel functional assay was designed for investigating the potential effect of variants within the RHD gene promoter. Three variants previously reported, that is, c.1-115A>C, c.1-110A>C, and c.1-83G>T, were tested by this approach.
resultsNo variant was identified in the 33 samples, suggesting that the molecular basis of the respective phenotypes remains to be resolved. Interestingly, beyond the ~200 base pair (bp) promoter region commonly described, another ~300 bp region located upstream appears to contain elements that positively regulate the transcriptional activity of the RHD gene. Also, the deleterious effect of the c.1-110A>C variant was confirmed, conversely to the two other variants, which did not show any functional alteration. DISCUSSION: Regulation of RH gene expression is likely to involve other levels of complexity that remain to be identified. Future investigations are necessary to characterize those critical genomic regions that potentially carry rare variants responsible for weakening or abolishment of D antigen expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.